如何设计一项能为衰弱老年人诊疗提供依据的高血压治疗试验:爱尔兰与英国临床医生调查
该调查面向爱尔兰和英国管理老年高血压的临床医生,用在线问卷评估其对不同收缩压(SBP)目标与治疗策略的试验设计接受度。共收到114份回复(48份初级保健、66份二级保健)。多数受访者愿将SBP<130 mm Hg的衰弱患者纳入放松治疗试验,也愿将SBP>150 mm Hg的患者纳入强化治疗试验。
要点
- 多数受访临床医生愿将SBP<130 mm Hg的衰弱老年人纳入放松降压治疗试验。
- 多数受访临床医生愿将SBP>150 mm Hg的老年人纳入强化降压治疗试验。
- 强化治疗可选策略包括按NICE指南选择下一步、加用新药足量或加两种药半量。
核心结论
- 多数受访临床医生愿将SBP>150 mm Hg且心血管风险高的老年人纳入强化治疗试验,或将SBP<130 mm Hg且衰弱的老年人纳入放松治疗试验。
研究设计与样本
- 多国临床医生调查,通过在线问卷链接在专业学会和社交网络中发放,共收到114份回复(48份初级保健、66份二级保健)。
主要发现
- 共收到114份回复,其中初级保健48份、二级保健66份。
- 多数受访者考虑将SBP<130 mm Hg的衰弱患者纳入放松治疗试验。
- 多数受访者考虑将SBP>150 mm Hg的患者纳入强化治疗试验。
关键数值与推荐
- 多数受访者愿招募SBP<130 mm Hg的衰弱患者进入放松治疗试验。
- 多数受访者愿招募SBP>150 mm Hg的患者进入强化治疗试验。
- 强化治疗策略包括按NICE指南选择下一步、加用新药足量或加两种药半量。
临床怎么用
- 设计老年衰弱高血压试验时,可参考临床医生对SBP<130 mm Hg放松治疗和SBP>150 mm Hg强化治疗的接受度来设定入组条件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: At all ages, randomised trials demonstrate lower mortality and cardiovascular disease incidence with blood pressure (BP) lowering. However, this may not generalise to older people with frailty. We aimed to determine the acceptability to clinicians of key aspects of trial designs using different BP targets and strategies to better manage hypertension in the context of frailty. METHODS: We conducted a multinational survey of clinicians managing hypertension in older people, distributed using an online survey link amongst professional societies and social networks. Questions described case histories of patients who were frail with different systolic blood pressures (SBP), treatment target, strategy and target trial population. RESULTS: In total, 114 responses were received (48 primary care, 66 secondary care). A majority would consider recruiting patients to a trial of relaxing treatment in those whose SBP < 130 mm Hg; a majority would consider recruiting to a trial intensifying treatment in patients with SBP > 150 mm Hg. Respondents elected to intensify treatment by: choosing the next step by NICE guidelines, adding a new treatment agent at full dose, or adding two agents at half dose. CONCLUSION: A majority of clinicians surveyed would recruit older people to a trial intensifying treatment where SBP is more than 150 mm Hg and where patients have high cardiovascular risk or to a trial relaxing treatment where the SBP is below 130 mm Hg and where the patient has frailty.
引用
- Veenhuizen M, Todd O, Anand A, et al. How to design a hypertension treatment trial that informs care of older people with frailty: a survey of clinicians in Ireland and the UK. Age Ageing. 2021. PMID: 33063103. doi:10.1093/ageing/afaa198
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。